Novartis AG
3-(1-OXO-5-(PIPERIDIN-4-YL)ISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES AND USES THEREOF

Last updated:

Abstract:

The present disclosure provides a compound of Formula (I), or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, stereoisomer, or tautomer thereof, wherein R.sub.1, R.sub.2, R.sub.3, R.sub.x, and n are as defined herein, and methods of making and using same. ##STR00001##

Status:
Application
Type:

Utility

Filling date:

13 Feb 2020

Issue date:

12 May 2022